Press Releases


Eckert & Ziegler Starts Technetium-99 Delivery in Brazil


​​​​​​​Eckert & Ziegler with Strong First Half of 2021


Eckert & Ziegler Receives Manufacturing Authorization for Thorium and Lutetium Compounds


Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America

27-07-2021, 17:27 CEST (Ad hoc press release)

​​​​​​​Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20%


Eckert & Ziegler: Affiliate Receives Additional NIAID Funding to Advance Pharmaceutical Development


Eckert & Ziegler and Telix Pharmaceuticals Enter Co-Promotion Agreement for Prostate Cancer Diagnostic in the United States


Eckert & Ziegler Granted Exclusive Distribution Rights by Telix Pharmaceuticals for Prostate Cancer Diagnostic


​​​​​​​Eckert & Ziegler: Record Income Due to Sale of Division and Strong Core Business


Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Medical on Yttrium-90 for Treating Liver Cancer

16-04-2021, 11:01 CEST (Ad hoc press release)

​​​​​​​Eckert & Ziegler Acquires Direct Majority Stake in Drug Developer PENTIXAPHARM


​​​​​​​Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin

12-04-2021, 21:12 CEST (Ad hoc press release)

Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

25-03-2021, 19:52 CET (Ad hoc press release)

​​​​​​​Eckert & Ziegler: Dividend Proposal EUR 0.45 per Share. Profit Increase in 2020. Positive Outlook for 2021.

24-03-2021, 14:09 CET (Ad hoc press release)

​​​​​​​Eckert & Ziegler Divests From Tumour Irradiation Business

17-03-2021, 23:49 CET (Ad hoc press release)

Eckert & Ziegler 2020: Earnings higher than expected


Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China


Eckert & Ziegler Wins Again Award for Excellent Training Quality


Eckert & Ziegler Wins Order for Hot Cell Construction from Dutch Research Center

04-02-2021, 19:28 CET (Ad hoc press release)

Eckert & Ziegler: PENTIXAPHARM Lead Candidate PENTIXAFOR Can Go in Phase III Study, EMA says


​​​​​​​Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA


Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care